Response to rapamycin analogs but not PD-1 inhibitors in PTEN-mutated metastatic non-small-cell lung cancer with high tumor mutational burden

Overview of attention for article published in Lung Cancer: Targets and Therapy, May 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 2 X users
reddit: 1 Redditor

video: 1 YouTube creator

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 24 Mendeley

Summary X Reddit YouTube Dimensions citations

So far, Dimensions has found 11 publications that cite this research output.

11

The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.

To be, or not to be: the dilemma of immunotherapy for non-small cell lung cancer harboring various driver mutations

Article in Journal of Cancer Research and Clinical Oncology (June 2023)

Mechanisms of drug resistance to immune checkpoint inhibitors in non-small cell lung cancer

Article in Frontiers in Immunology (February 2023)

Drug Resistance in Lung Cancer

Book chapter (November 2022)